Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12582582 | Oral care compositions and methods of use | 🖼🧊📄§ | 2026-03-24 | 2041-08-06 | 0 | 31 |
| 12582581 | Laminate sheet for cosmetic, and cosmetic set | 🖼🧊📄§ | 2026-03-24 | 2043-03-24 | 0 | 31 |
| 12582587 | Sunscreen composition and methods of protection from ultraviolet and visible light | 🖼🧊📄§ | 2026-03-24 | 2044-07-25 | 0 | 31 |
| 12582590 | Transparent liquid composition and cosmetic containing said composition | 🖼🧊📄§ | 2026-03-24 | 2042-09-22 | 0 | 31 |
| 12582588 | Solid cosmetic composition for blocking ultraviolet radiation having water resistance and cleansing properties | 🖼🧊📄§ | 2026-03-24 | 2041-01-21 | 0 | 31 |
| 12582592 | Flavor or aroma deterioration inhibitor containing theanaphthoquinone and analogues thereof as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2039-08-01 | 0 | 31 |
| 12582595 | System and method for priming eye cosmetics | 🖼🧊📄§ | 2026-03-24 | 2043-10-12 | 0 | 31 |
| 12582596 | Solid composition for keratin fibers | 🖼🧊📄§ | 2026-03-24 | 2041-12-07 | 0 | 31 |
| 12582598 | Topical anti-inflammatory pharmaceutical composition comprising Zileuton | 🖼🧊📄§ | 2026-03-24 | 2039-12-30 | 0 | 31 |
| 12582594 | Polymer carbon nitride, specific crystal form of said polymer carbon nitride, and ultraviolet ray-blocking use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-12-06 | 0 | 31 |
| 12582600 | Stable gel composition having high oil content, and preparation method therefor and application thereof | 🖼🧊📄§ | 2026-03-24 | 2040-08-27 | 0 | 31 |
| 12582605 | Extended release formulations of cannabinoids | 🖼🧊📄§ | 2026-03-24 | 2039-07-16 | 0 | 31 |
| 12582602 | Tableted cannabinoid chewing gum with tableted modules | 🖼🧊📄§ | 2026-03-24 | 2043-10-24 | 0 | 31 |
| 12582604 | Stable solid dispersion of a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor | 🖼🧊📄§ | 2026-03-24 | 2040-01-23 | 0 | 31 |
| 12582601 | Orodispersible powder composition | 🖼🧊📄§ | 2026-03-24 | 2041-12-21 | 0 | 31 |
| 12582609 | Cancer vaccines | 🖼🧊📄§ | 2026-03-24 | 2036-10-21 | 0 | 31 |
| 12582608 | Coatings for gastric residence dosage forms | 🖼🧊📄§ | 2026-03-24 | 2040-03-19 | 0 | 31 |
| 12582606 | Tablet and method for producing tablet | 🖼🧊📄§ | 2026-03-24 | 2040-04-14 | 0 | 31 |
| 12582607 | Implantable medical devices for extended release of therapeutic agents | 🖼🧊📄§ | 2026-03-24 | 2042-09-16 | 0 | 31 |
| 12582616 | Molecular targets for modulation of dissociative and associative states | 🖼🧊📄§ | 2026-03-24 | 2041-08-09 | 0 | 31 |
| 12582615 | Topical analgesic gel compositions | 🖼🧊📄§ | 2026-03-24 | 2043-03-07 | 0 | 31 |
| 12582618 | Bis-biguanide compounds, pharmaceutical compositions and uses in managing cancer | 🖼🧊📄§ | 2026-03-24 | 2040-02-28 | 0 | 31 |
| 12582624 | Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use | 🖼🧊📄§ | 2026-03-24 | 2041-04-21 | 0 | 31 |
| 12582622 | Sodium oxybate to treat idiopathic hypersomnia | 🖼🧊📄§ | 2026-03-24 | 2041-10-08 | 0 | 31 |
| 12582623 | Composition comprising EPA, MA and leucine for improving muscle function | 🖼🧊📄§ | 2026-03-24 | 2040-10-30 | 0 | 31 |
| 12582621 | Compositions and methods for delivering pharmaceutical agents | 🖼🧊📄§ | 2026-03-24 | 2041-06-11 | 0 | 31 |
| 12582625 | Methods for treating neuroblastoma | 🖼🧊📄§ | 2026-03-24 | 2044-12-23 | 0 | 31 |
| 12582627 | MCT formulations for improving cognitive functions | 🖼🧊📄§ | 2026-03-24 | 2041-05-17 | 0 | 31 |
| 12582628 | Methods for treating breast cancer | 🖼🧊📄§ | 2026-03-24 | 2042-04-13 | 0 | 31 |
| 12582630 | Cannabis extracts and methods of preparing and using same | 🖼🧊📄§ | 2026-03-24 | 2042-04-01 | 0 | 31 |
| 12582633 | Methods of treating severe acute respiratory syndrome | 🖼🧊📄§ | 2026-03-24 | 2041-04-08 | 0 | 31 |
| 12582637 | Topical formulation for intradermal application and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2039-08-29 | 0 | 31 |
| 12582636 | Pharmaceutical composite formulation comprising proton pump inhibitor and antacid | 🖼🧊📄§ | 2026-03-24 | 2041-01-22 | 0 | 31 |
| 12582634 | Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine | 🖼🧊📄§ | 2026-03-24 | 2040-06-10 | 0 | 31 |
| 12582640 | Treatment of lower respiratory tract infection with tradipitant | 🖼🧊📄§ | 2026-03-24 | 2041-03-24 | 0 | 31 |
| 12582641 | Sulfur-containing compound based on glutarimide skeleton and application thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-25 | 0 | 31 |
| 12582642 | Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus | 🖼🧊📄§ | 2026-03-24 | 2041-05-28 | 0 | 31 |
| 12582646 | Method for treating drug or alcohol dependency | 🖼🧊📄§ | 2026-03-24 | 2040-01-03 | 0 | 31 |
| 12582643 | Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy | 🖼🧊📄§ | 2026-03-24 | 2041-03-03 | 0 | 31 |
| 12582647 | Systems and methods for treating an opioid-induced adverse pharmacodynamic response | 🖼🧊📄§ | 2026-03-24 | 2044-02-08 | 0 | 31 |
| 12582644 | O-GlcNAc transferase inhibitors and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2039-08-29 | 0 | 31 |
| 12582651 | Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate | 🖼🧊📄§ | 2026-03-24 | 2041-12-30 | 0 | 31 |
| 12582653 | Method for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-24 | 2040-06-24 | 0 | 31 |
| 12582655 | Methods of treating disorders using CSFIR inhibitors | 🖼🧊📄§ | 2026-03-24 | 2045-10-21 | 0 | 31 |
| 12582656 | Nucleotide analogues | 🖼🧊📄§ | 2026-03-24 | 2041-03-23 | 0 | 31 |
| 12582654 | Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereof | 🖼🧊📄§ | 2026-03-24 | 2040-12-21 | 0 | 31 |
| 12582657 | Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12582660 | Inhibitors of the RAS oncoprotein, methods of making and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2039-05-10 | 0 | 31 |
| 12582659 | Stimulant composition and process for making same | 🖼🧊📄§ | 2026-03-24 | 2045-09-09 | 0 | 31 |
| 12582667 | Compositions and methods to treat metastatic gastrointestinal cancer | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |